Calcitonin gene-related peptide inhibits angiotensin II-mediated vasoconstriction in human radial arteries: Role of the Kir channel

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 2, 2008, Pages 370-375

  Zulli, Anthony ^a,b   Ye, Bei ^b   Wookey, Peter J ^a,b   Buxton, Brian F ^b   Hare, David L ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; ALPHA CALCITONIN GENE RELATED PEPTIDE; ANGIOTENSIN II; APAMIN; BARIUM; CHARYBDOTOXIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; N(G) NITROARGININE METHYL ESTER; POTASSIUM CHANNEL;

ADULT; AGED; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIAL ARTERY; VASODILATATION;

4-AMINOPYRIDINE; AGED; ANGIOTENSIN II; APAMIN; BARIUM; CALCITONIN GENE-RELATED PEPTIDE; CHARYBDOTOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; MIDDLE AGED; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RADIAL ARTERY; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 48649099394     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.12.064     Document Type: Article

References (36)

1. Ruengsakulrach P., Sinclair R., Komeda M., Raman J., Gordon I., and Buxton B. Comparative histopathology of radial artery versus internal thoracic artery and risk factors for development of intimal hyperplasia and atherosclerosis. Circulation 100 19 Suppl (1999) II139-II144
2. de Gasparo M., Catt K.J., Inagami T., Wright J.W., and Unger T. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52 (2000) 415-472
3. Yoshimoto R., Mitsui-Saito M., Ozaki H., and Karaki H. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery. Br J Pharmacol 123 (1998) 1645-1654
4. Tippins J.R. CGRP: a novel neuropeptide from the calcitonin gene is the most potent vasodilator known. J Hypertens Suppl 4 (1986) S102-S105
5. Wimalawansa S.J. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol 11 (1997) 167-239
6. Li J., and Wang D.H. Development of angiotensin II-induced hypertension: role of CGRP and its receptor. J Hypertens 23 (2005) 113-118
7. Rosenfeld M.G., Mermod J.J., Amara S.G., Swanson L.W., Sawchenko P.E., Rivier J., et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304 (1983) 129-135
8. Amara S.G., Arriza J.L., Leff S.E., Swanson L.W., Evans R.M., and Rosenfeld M.G. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 229 (1985) 1094-1097
9. Wimalawansa S.J., Morris H.R., Etienne A., Blench I., Panico M., and MacIntyre I. Isolation, purification and characterization of beta-hCGRP from human spinal cord. Biochem Biophys Res Commun 167 (1990) 993-1000
10. Du Y.H., Peng J., Huang Z.Z., Jiang D.J., Deng H.W., and Li Y.J. Delayed cardioprotection afforded by nitroglycerin is mediated by alpha-CGRP via activation of inducible nitric oxide synthase. Int J Cardiol 93 (2004) 49-54
11. Wang W., Sun W., and Wang X. Intramuscular gene transfer of CGRP inhibits neointimal hyperplasia after balloon injury in the rat abdominal aorta. Am J Physiol Heart Circ Physiol 287 (2004) H1582-H1589
12. Li Y., Fiscus R.R., Wu J., Yang L., and Wang X. The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells. Neuropeptides 31 (1997) 503-509
13. Chowdhury U.K., Airan B., Mishra P.K., Kothari S.S., Subramaniam G.K., Ray R., et al. Histopathology and morphometry of radial artery conduits: basic study and clinical application. Ann Thorac Surg 78 (2004) 1614-1621
14. Hamilton C.A., Berg G., McIntyre M., McPhaden A.R., Reid J.L., and Dominiczak A.F. Effects of nitric oxide and superoxide on relaxation in human artery and vein. Atherosclerosis 133 (1997) 77-86
15. He G.W., and Yang C.Q. Comparative study on calcium channel antagonists in the human radial artery: clinical implications. J Thorac Cardiovasc Surg 119 (2000) 94-100
16. He G.W., Angus J.A., and Rosenfeldt F.L. Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: relevance to coronary bypass graft surgery. J Cardiovasc Pharmacol 12 (1988) 12-22
17. Petersen K.A., Lassen L.H., Birk S., Lesko L., and Olesen J. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 77 (2005) 202-213
18. Harrison W.E., Mellor A.J., Clark J., and Singer D.R. Vasodilator pre-treatment of human radial arteries: comparison of effects of phenoxybenzamine vs papaverine on norepinephrine-induced contraction in vitro. Eur Heart J 22 (2001) 2209-2216
19. Chrissobolis S., Ziogas J., Chu Y., Faraci F.M., and Sobey C.G. Role of inwardly rectifying K(+) channels in K(+)-induced cerebral vasodilatation in vivo. Am J Physiol Heart Circ Physiol 279 (2000) H2704-H2712
20. Sobey C.G. Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol 21 (2001) 28-38
21. Portaluppi F., Vergnani L., Margutti A., Ambrosio M.R., Bondanelli M., Trasforini G., et al. Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man. J Clin Endocrinol Metab 77 (1993) 816-820
22. Fujioka S., Sasakawa O., Kishimoto H., Tsumura K., and Morii H. The antihypertensive effect of calcitonin gene-related peptide in rats with norepinephrine- and angiotensin II-induced hypertension. J Hypertens 9 (1991) 175-179
23. Itabashi A., Kashiwabara H., Shibuya M., Tanaka K., Masaoka H., Katayama S., et al. The interaction of calcitonin gene-related peptide with angiotensin II on blood pressure and renin release. J Hypertens Suppl 6 (1988) S418-S420
24. Kawasaki H., Inaizumi K., Nakamura A., Hobara N., and Kurosaki Y. Chronic angiotensin II inhibition increases levels of calcitonin gene-related peptide mRNA of the dorsal root ganglia in spontaneously hypertensive rats. Hypertens Res 26 (2003) 257-263
25. Li J., Zhao H., Supowit S.C., DiPette D.J., and Wang D.H. Activation of the renin-angiotensin system in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. J Hypertens 22 (2004) 1345-1349
26. Jernbeck J., and Samuelson U.E. Effects of lidocaine and calcitonin gene-related peptide (CGRP) on isolated human radial arteries. J Reconstr Microsurg 9 (1993) 361-365
27. Qin X.P., Ye F., Liao D.F., and Li Y.J. Involvement of calcitonin gene-related peptide in the depressor effects of losartan and perindopril in rats. Eur J Pharmacol 464 (2003) 63-67
28. Deng P.Y., Ye F., Cai W.J., Tan G.S., Hu C.P., Deng H.W., et al. Stimulation of calcitonin gene-related peptide synthesis and release: mechanisms for a novel antihypertensive drug, rutaecarpine. J Hypertens 22 (2004) 1819-1829
29. Hu C.P., Xiao L., Deng H.W., and Li Y.J. The depressor and vasodilator effects of rutaecarpine are mediated by calcitonin gene-related peptide. Planta Med 69 (2003) 125-129
30. Deng P.Y., and Li Y.J. Calcitonin gene-related peptide and hypertension. Peptides 26 (2005) 1676-1685
31. Girgis S.I., Macdonald D.W., Stevenson J.C., Bevis P.J., Lynch C., Wimalawansa S.J., et al. Calcitonin gene-related peptide: potent vasodilator and major product of calcitonin gene. Lancet 2 (1985) 14-16
32. Brain S.D., and Grant A.D. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84 (2004) 903-934
33. Bell D., and McDermott B.J. Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho)physiological significance. Pharmacol Rev 48 (1996) 253-288
34. Raddino R., Pela G., Manca C., Barbagallo M., D'Aloia A., Passeri M., et al. Mechanism of action of human calcitonin gene-related peptide in rabbit heart and in human mammary arteries. J Cardiovasc Pharmacol 29 (1997) 463-470
35. Gray D.W., and Marshall I. Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta. Eur J Pharmacol 212 (1992) 37-42
36. Wisskirchen F.M., Burt R.P., and Marshall I. Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens. Br J Pharmacol 123 (1998) 1673-1683